Download PDF
Semin Respir Crit Care Med 2021; 42(02): 171-175
DOI: 10.1055/s-0041-1725059
Review Article

Trends in Mortality of Acute Pulmonary Embolism

An Thi Nhat Ho
1   Division of Pulmonary, Critical Care and Sleep Medicine, Saint Louis University School of Medicine, St. Louis, Missouri
,
Nelly Bellamy
2   Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri
,
Soophia K. Naydenov
1   Division of Pulmonary, Critical Care and Sleep Medicine, Saint Louis University School of Medicine, St. Louis, Missouri
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Despite substantial advances in the diagnosis and management, pulmonary embolism (PE) continues to be a significant cause of mortality. In this article, we provide a concise overview of the evolution of worldwide mortality trends related to PE. Despite the data being derived mainly from observational studies, there is a clear trend toward decreasing mortality over time from PE. Whether this truly represents a treatment effect or is more related to increased diagnosis of small PEs is not fully clear. Modern approaches to PE management such as the PE response teams have the potential to further reduce the mortality from PE.

Keywords

pulmonary embolism - mortality - PERT - anticoagulation


Publication History

Article published online:
10 March 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Essien EO, Rali P, Mathai SC. Pulmonary embolism. Med Clin North Am 2019; 103 (03) 549-564
    CrossrefPubMedGoogle Scholar
  • 2 Jaff MR, McMurtry MS, Archer SL. et al; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, American Heart Association Council on Peripheral Vascular Disease, American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011; 123 (16) 1788-1830
    CrossrefPubMedGoogle Scholar
  • 3 Gupta R, Fortman DD, Morgenstern DR, Cooper CJ. Short- and long-term mortality risk after acute pulmonary embolism. Curr Cardiol Rep 2018; 20 (12) 135
    CrossrefPubMedGoogle Scholar
  • 4 Zakai NA, McClure LA, Judd SE. et al. Racial and regional differences in venous thromboembolism in the United States in 3 cohorts. Circulation 2014; 129 (14) 1502-1509
    CrossrefPubMedGoogle Scholar
  • 5 Martin KA, Molsberry R, Cuttica MJ, Desai KR, Schimmel DR, Khan SS. Time trends in pulmonary embolism mortality rates in the United States, 1999 to 2018. J Am Heart Assoc 2020; 9 (17) e016784
    CrossrefPubMedGoogle Scholar
  • 6 Jiménez D, de Miguel-Díez J, Guijarro R. et al; RIETE Investigators. Trends in the management and outcomes of acute pulmonary embolism: analysis from the RIETE registry. J Am Coll Cardiol 2016; 67 (02) 162-170
    CrossrefPubMedGoogle Scholar
  • 7 Bikdeli B, Wang Y, Jimenez D. et al. Pulmonary embolism hospitalization, readmission, and mortality rates in US older adults, 1999-2015. JAMA 2019; 322 (06) 574-576
    CrossrefPubMedGoogle Scholar
  • 8 Kempny A, McCabe C, Dimopoulos K. et al. Incidence, mortality and bleeding rates associated with pulmonary embolism in England between 1997 and 2015. Int J Cardiol 2019; 277: 229-234
    CrossrefPubMedGoogle Scholar
  • 9 Lehnert P, Lange T, Møller CH, Olsen PS, Carlsen J. Acute pulmonary embolism in a national Danish cohort: increasing incidence and decreasing mortality. Thromb Haemost 2018; 118 (03) 539-546
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Ienghong K, Kulsutcharit K, Apiratwarakul K, Gaysonsiri D, Mitsungnern T, Bhudhisawasdi V. Characteristics and mortality in high-, intermediate-, and low-risk acute pulmonary embolism patients in the emergency department. J Med Assoc Thai 2020; 103 (06) 42-46
    PubMedGoogle Scholar
  • 11 Chuang LH, Gumbs P, van Hout B. et al. Health-related quality of life and mortality in patients with pulmonary embolism: a prospective cohort study in seven European countries. Qual Life Res 2019; 28 (08) 2111-2124
    CrossrefPubMedGoogle Scholar
  • 12 Becattini C, Agnelli G, Lankeit M. et al. Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model. Eur Respir J 2016; 48 (03) 780-786
    CrossrefPubMedGoogle Scholar
  • 13 Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353 (9162): 1386-1389
    CrossrefPubMedGoogle Scholar
  • 14 Barco S, Mahmoudpour SH, Valerio L. et al. Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database. Lancet Respir Med 2020; 8 (03) 277-287
    CrossrefPubMedGoogle Scholar
  • 15 Olié V, Bonaldi C. Pulmonary embolism: Does the seasonal effect depend on age? A 12-year nationwide analysis of hospitalization and mortality. Thromb Res 2017; 150: 96-100
    CrossrefPubMedGoogle Scholar
  • 16 Olié V, Fuhrman C, Chin F, Lamarche-Vadel A, Scarabin PY, de Peretti C. Time trends in pulmonary embolism mortality in France, 2000-2010. Thromb Res 2015; 135 (02) 334-338
    CrossrefPubMedGoogle Scholar
  • 17 Shiraev TP, Omari A, Rushworth RL. Trends in pulmonary embolism morbidity and mortality in Australia. Thromb Res 2013; 132 (01) 19-25
    CrossrefPubMedGoogle Scholar
  • 18 Hoffmann B, Gross CR, Jöckel KH, Kröger K. Trends in mortality of pulmonary embolism--an international comparison. Thromb Res 2010; 125 (04) 303-308
    CrossrefPubMedGoogle Scholar
  • 19 Lilienfeld DE. Decreasing mortality from pulmonary embolism in the United States, 1979-1996. Int J Epidemiol 2000; 29 (03) 465-469
    PubMedGoogle Scholar
  • 20 Barbar S, Noventa F, Rossetto V. et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 2010; 8 (11) 2450-2457
    CrossrefPubMedGoogle Scholar
  • 21 Roderick P, Ferris G, Wilson K, Halls H, Jackson D, Collins R. et al. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. Health Technol Assess 2005; 9 (49) iii-iv , ix–x, 1–78
    CrossrefPubMedGoogle Scholar
  • 22 Smith SB, Geske JB, Kathuria P. et al. Analysis of national trends in admissions for pulmonary embolism. Chest 2016; 150 (01) 35-45
    CrossrefPubMedGoogle Scholar
  • 23 Rosovsky R, Zhao K, Sista A, Rivera-Lebron B, Kabrhel C. Pulmonary embolism response teams: purpose, evidence for efficacy, and future research directions. Res Pract Thromb Haemost 2019; 3 (03) 315-330
    CrossrefPubMedGoogle Scholar
  • 24 Merli GJ. Pulmonary embolism in 2017: How we got here and where are we going?. Tech Vasc Interv Radiol 2017; 20 (03) 128-134
    CrossrefPubMedGoogle Scholar
  • 25 Smith SB, Geske JB, Maguire JM, Zane NA, Carter RE, Morgenthaler TI. Early anticoagulation is associated with reduced mortality for acute pulmonary embolism. Chest 2010; 137 (06) 1382-1390
    CrossrefPubMedGoogle Scholar
  • 26 Chaudhury P, Gadre SK, Schneider E. et al. Impact of multidisciplinary pulmonary embolism response team availability on management and outcomes. Am J Cardiol 2019; 124 (09) 1465-1469
    CrossrefPubMedGoogle Scholar
  • 27 Eldredge JB, Spyropoulos AC. Direct oral anticoagulants in the treatment of pulmonary embolism. Curr Med Res Opin 2018; 34 (01) 131-140
    CrossrefPubMedGoogle Scholar
  • 28 Schulman S, Kakkar AK, Goldhaber SZ. et al; RE-COVER II Trial Investigators. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis. Circulation 2014; 129 (07) 764-772
    CrossrefPubMedGoogle Scholar
  • 29 Büller HR, Prins MH, Lensin AW. et al; EINSTEIN–PE Investigators. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012; 366 (14) 1287-1297
    CrossrefPubMedGoogle Scholar
  • 30 Büller HR, Décousus H, Grosso MA. et al; Hokusai-VTE Investigators. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 2013; 369 (15) 1406-1415
    CrossrefPubMedGoogle Scholar
  • 31 Agnelli G, Buller HR, Cohen A. et al; AMPLIFY Investigators. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 2013; 369 (09) 799-808
    CrossrefPubMedGoogle Scholar
  • 32 Stein PD, Matta F, Hughes PG, Hughes MJ. Adjunctive therapy and mortality in patients with unstable pulmonary embolism. Am J Cardiol 2020; 125 (12) 1913-1919
    CrossrefPubMedGoogle Scholar
  • 33 Alqahtani F, Munir MB, Aljohani S, Tarabishy A, Almustafa A, Alkhouli M. Surgical thrombectomy for pulmonary embolism: updated performance rates and outcomes. Tex Heart Inst J 2019; 46 (03) 172-174
    CrossrefPubMedGoogle Scholar
  • 34 Fukuda I, Daitoku K. Surgical embolectomy for acute pulmonary thromboembolism. Ann Vasc Dis 2017; 10 (02) 107-114
    CrossrefPubMedGoogle Scholar
  • 35 Klil-Drori AJ, Coulombe J, Suissa S, Hirsch A, Tagalakis V. Temporal trends in outpatient management of incident pulmonary embolism and associated mortality. Thromb Res 2018; 161: 111-116
    CrossrefPubMedGoogle Scholar